A modular Phase I study of lenalidomide and paclitaxel in metastatic castration-resistant prostate cancer following prior taxane therapy. [electronic resource]
Producer: 20100205Description: 811-5 p. digitalISSN:- 1432-0843
- Aged
- Anemia -- chemically induced
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bridged-Ring Compounds -- administration & dosage
- Combined Modality Therapy
- Diarrhea -- chemically induced
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Humans
- Lenalidomide
- Male
- Middle Aged
- Nausea -- chemically induced
- Neutropenia -- chemically induced
- Orchiectomy
- Paclitaxel -- administration & dosage
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
- Survival Analysis
- Taxoids -- administration & dosage
- Thalidomide -- administration & dosage
- Treatment Outcome
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.